Dr. Owen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
460 W 10th Ave
Columbus, OH 43210Phone+1 614-293-6529
Education & Training
The Ohio State UniversityM.Sc., Clinical Research, 2015 - 2017
Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2014 - 2017
New York Presbyterian Hospital (Cornell Campus)Chief Residency, Internal Medicine, 2013 - 2014
SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 2010 - 2013
University College of Dublin National Univ SOMClass of 2010
Certifications & Licensure
OH State Medical License 2014 - 2026
NY State Medical License 2013 - 2015
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Evaluating the effect of immune checkpoint inhibitor treatment on chronic obstructive pulmonary disease in lung cancer patients.Anet Greib, Songzhu Zhao, Michelle Ploch, Jonathan Henricks, Robert Easterling
Oncoimmunology. 2025-12-01 - Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.3.Dwight H Owen, Nofisat Ismaila, Amith Ahluwalia, Jill Feldman, Shirish Gadgeel
Journal of Clinical Oncology. 2025-04-01 - CLO25-080: Outcomes of Extreme Low PD-L1 Expression in Advanced Non-Small Cell Lung Cancer: Implications for Treatment Approaches.Alexander Rudich, Natalie Johns, Songzhu Zhao, Kenneth Chian, Po-Lan Su
Journal of the National Comprehensive Cancer Network. 2025-03-28
Press Mentions
“Really Impactful” New Guidelines for Stage IV NSCLC With Driver AlterationsAugust 9th, 2023- 'No' to Anti-VEGF-Chemo Combo in NSCLC Sans Driver AlterationsFebruary 10th, 2023
- High BMI Linked to Better Survival for Cancer Patients Treated with ICI, but for Men OnlySeptember 22nd, 2022
- Join now to see all
Professional Memberships
- Fellow
- Member
- Member
- Member
- Member
- International Association for the Study of Lung CancerMember
- North American Neuroendocrine Tumor SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
